companydata.dkcompanydata.dk

Renovaro Biosciences Denmark ApS: Financial statements 2016

CVR: 26027322

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

Renovaro Biosciences Denmark ApS (CVR 26027322) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -4,965,331 and a net result of DKK -10,661,607 compared with DKK -20,352,670 the year before. Equity in the 2016 report amounted to DKK -51,965,491. The company had 2 employees in the financial year.

Gross Profit
DKK -4,965,331
Profit/Loss
DKK -10,661,607
Equity
DKK -51,965,491
Total Assets
DKK 5,254,271
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--5M-10.7M-52M2
2015--17.4M-20.4M-41.3M-
2014--8.5M-11.5M-21M-
2013--5.6M-10.6M-9.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Renovaro Biosciences Denmark ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

Renovaro Biosciences Denmark ApS: The 2015 annual report is outJul 8, 2016

Renovaro Biosciences Denmark ApS has published its annual report for 2015. Gross profit came to DKK -17,425,853, and the net result was DKK -20,352,670.

Jacob Rosenberg leaves the board of Renovaro Biosciences Denmark ApSJun 26, 2016

As of June 26, 2016, Jacob Rosenberg has left the board of directors of Renovaro Biosciences Denmark ApS.

About Renovaro Biosciences Denmark ApS

Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.

Source: annual report 2026, Danish Business Authority